Aptorum Group (Aptorum Group) Other Current Receivables : $0.20 Mil (As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Aptorum Group Other Current Receivables?

Aptorum Group's Other Current Receivables for the quarter that ended in Jun. 2023 was $0.20 Mil.

Aptorum Group's quarterly Other Current Receivables increased from Jun. 2022 ($0.24 Mil) to Dec. 2022 ($0.36 Mil) but then stayed the same from Dec. 2022 ($0.36 Mil) to Jun. 2023 ($0.20 Mil).

Aptorum Group's annual Other Current Receivables declined from Dec. 2020 ($0.28 Mil) to Dec. 2021 ($0.20 Mil) but then increased from Dec. 2021 ($0.20 Mil) to Dec. 2022 ($0.36 Mil).

Aptorum Group Other Current Receivables Historical Data

The historical data trend for Aptorum Group's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptorum Group Other Current Receivables Chart

Aptorum Group Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Current Receivables

Get a 7-Day Free Trial

1.13

0.45

0.28

0.20

0.36

Aptorum Group Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Other Current Receivables	Get a 7-Day Free Trial							0.37	0.20	0.24	0.36	0.20

Aptorum Group Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Aptorum Group Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Aptorum Group's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptorum Group (Aptorum Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptorum Group Ltd (NAS:APM) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

17 Hanover Square, London, GBR, W1S 1BN

Website

https://www.aptorumgroup.com

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.